Acute Chest Syndrome is Associated with Single Nucleotide Polymorphism-defined Beta Globin Cluster Haplotype in Children with Sickle Cell Anaemia
Overview
Authors
Affiliations
Genetic diversity at the human β-globin locus has been implicated as a modifier of sickle cell anaemia (SCA) severity. However, haplotypes defined by restriction fragment length polymorphism sites across the β-globin locus have not been consistently associated with clinical phenotypes. To define the genetic structure at the β-globin locus more thoroughly, we performed high-density single nucleotide polymorphism (SNP) mapping in 820 children who were homozygous for the sickle cell mutation (HbSS). Genotyping results revealed very high linkage disequilibrium across a large region spanning the locus control region and the HBB (β-globin gene) cluster. We identified three predominant haplotypes accounting for 96% of the β(S) -carrying chromosomes in this population that could be distinguished using a minimal set of common SNPs. Consistent with previous studies, fetal haemoglobin level was significantly associated with β(S) -haplotypes. After controlling for covariates, an association was detected between haplotype and rate of hospitalization for acute chest syndrome (ACS) (incidence rate ratio 0·51, 95% confidence interval 0·29-0·89) but not incidence rate of vaso-occlusive pain or presence of silent cerebral infarct (SCI). Our results suggest that these SNP-defined β(S) -haplotypes may be associated with ACS, but not pain or SCI in a study population of children with SCA.
Genetic Variation and Sickle Cell Disease Severity: A Systematic Review and Meta-Analysis.
Kirkham J, Estepp J, Weiss M, Rashkin S JAMA Netw Open. 2023; 6(10):e2337484.
PMID: 37851445 PMC: 10585422. DOI: 10.1001/jamanetworkopen.2023.37484.
Single nucleotide polymorphisms and sickle cell disease-related pain: a systematic review.
Gehling G, Powell-Roach K, Wilkie D, Dungan J Front Pain Res (Lausanne). 2023; 4:1223309.
PMID: 37781219 PMC: 10538969. DOI: 10.3389/fpain.2023.1223309.
Belvitch P, Casanova N, Sun X, Camp S, Sammani S, Brown M Transl Res. 2022; 244:56-74.
PMID: 35181549 PMC: 9119916. DOI: 10.1016/j.trsl.2022.02.002.
Biomarker signatures of sickle cell disease severity.
Du M, Van Ness S, Gordeuk V, Nouraie S, Nekhai S, Gladwin M Blood Cells Mol Dis. 2018; 72:1-9.
PMID: 29778312 PMC: 6087499. DOI: 10.1016/j.bcmd.2018.05.001.
Mnika K, Pule G, Dandara C, Wonkam A OMICS. 2016; 20(10):565-574.
PMID: 27636225 PMC: 5067801. DOI: 10.1089/omi.2016.0105.